MOUNT BLUE SKY, Colorado – If you have any interest in taking part in a fascinating study with the University of Colorado’s Department of Emergency Medicine, they’re seeking participants for a study on altitude sickness prevention on Mount Blue Sky.
The study is focused on the use of prochlorperazine (more commonly known as Compazine) to treat acute mountain sickness. Prochlorperazine is most commonly used to treat nausea and vomiting, and occasionally schizophrenia and anxiety not caused by a mental health condition.
Those who participate in the study will meet in Golden, Colorado, where they’ll either be given a placebo drug or the prochlorperazine, in addition to a breakfast. From there, they’ll be brought to Summit Lake near Mount Blue Sky, given lunch, a second dose of the drug, and dinner, in addition to going on a guided hike and spending the night on the mountain. Participants will return to the original meeting point the following morning, after being given breakfast.
“This study is designed for the researcher to learn more about how to prevent acute mountain sickness. Having a better way to help prevent acute mountain sickness would be very beneficial to all travelers to altitude which includes people traveling for fun and recreation, native populations, workers, rescuers and military personnel.“
Those interested are asked to reach out to the research team or submit their information to the form on the study website. Dates include August 5-6, 7-8, and 27-28.
